Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo

被引:223
作者
Chen, Pei-Ni
Chu, Shu-Chen
Chiou, Hui-Ling
Chiang, Chui-Liang
Yang, Shun-Fa
Hsieh, Yih-Shou
机构
[1] Chung Shan Med Univ, Inst Biochem, Sect 1, Taichung 02, Taiwan
[2] Cent Taiwan Univ Sci & Technol, Dept Food Sci, Taichung 406, Taiwan
[3] Chung Shan Med Univ, Sch Med Technol, Taichung 402, Taiwan
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2005年 / 53卷 / 02期
关键词
D O I
10.1207/s15327914nc5302_12
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dietary polyphenols, including anthocyanins, are suggested to be involved in the protective effects of fruits and vegetables against cancer However, anticancer effects of peonidin 3-glucoside have not been clearly demonstrated, with only limited studies being available concerning the inhibitory effect of cyanidin 3-glucoside for tumor cell growth. Therefore, in this study, we have isolated and identified the two bioactive compounds, peonidin 3-glucoside and cyanidin 3-glucoside, from Oryza saliva L. indica, to treat various cancer cells. The results showed that, among analyzed cell lines, HS578T was the most sensitive to peonidin 3-glucoside and cyanidin 3-glucoside. Treatment with peonidin 3-glucoside or cyanidin 3-glucoside resulted in a strong inhibitory effect on cell growth via G2/M arrest. Regarding cell cycle-related proteins, peonidin 3-glucoside treatment resulted in down-regulation of protein levels of cyclin-dependent kinase (CDK)-1, CDK-2, cyclin B1, and cyclin E, whereas cyanidin 3-glucoside could decrease the protein levels of CDK-1, CDK-2, cyclin B1, and cyclin D1. In addition, cyanidin 3-glucoside or peonidin 3-glucoside also induced caspase-3 activation, chromatin condensation, and cell death. Furthermore, anthocyanins from O. sativa L. indica were evidenced by their inhibition on the growth of Lewis lung carcinoma cells in vivo.
引用
收藏
页码:232 / 243
页数:12
相关论文
共 36 条
[1]   Enhanced sensitivity to irinotecan by Cdk1 inhibition in the p53-deficient HT29 human colon cancer cell line [J].
Abal, M ;
Bras-Goncalves, R ;
Judde, JG ;
Fsihi, H ;
de Cremoux, P ;
Louvard, D ;
Magdelenat, H ;
Robine, S ;
Poupon, MF .
ONCOGENE, 2004, 23 (09) :1737-1744
[2]   Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula [J].
Bagchi, D ;
Sen, CK ;
Bagchi, M ;
Atalay, M .
BIOCHEMISTRY-MOSCOW, 2004, 69 (01) :75-+
[3]   Flavonoid compounds in maintenance of prostate health and prevention and treatment of cancer [J].
Brown, DM ;
Kelly, GE ;
Husband, AJ .
MOLECULAR BIOTECHNOLOGY, 2005, 30 (03) :253-270
[4]   Disruption of MKK4 signaling reveals its tumor-suppressor role in embryonic stem cells [J].
Cazillis, M ;
Bringuier, AF ;
Delautier, D ;
Buisine, M ;
Bernuau, D ;
Gespach, C ;
Groyer, A .
ONCOGENE, 2004, 23 (27) :4735-4744
[5]  
CHEN PN, 2006, IN PRESS CANC LETT
[6]  
Chiang WL, 2002, CANCER LETT, V188, P199, DOI 10.1016/S0304-3835(02)00078-2
[7]   CDK INHIBITORS - ON THE THRESHOLD OF CHECKPOINTS AND DEVELOPMENT [J].
ELLEDGE, SJ ;
HARPER, JW .
CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (06) :847-852
[8]   INHIBITION OF PROSTATE-CANCER GROWTH BY ESTRAMUSTINE AND COLCHICINE [J].
FAKIH, M ;
YAGODA, A ;
REPLOGLE, T ;
LEHR, JE ;
PIENTA, KJ .
PROSTATE, 1995, 26 (06) :310-315
[9]  
GRANA X, 1995, ONCOGENE, V11, P211
[10]   Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms [J].
Hou, DX ;
Kai, K ;
Li, JJ ;
Lin, SG ;
Terahara, N ;
Wakamatsu, M ;
Fujii, M ;
Young, MR ;
Colburn, N .
CARCINOGENESIS, 2004, 25 (01) :29-36